Earnings
ATNM
11.27
+3.49%
0.38
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2019-12-31
9.25M
--
--
--
--
--
0.00
--
--
--
785.72K
48.09K
10.09M
1.14M
--
--
--
--
--
--
441.19K
1.58M
11.67M
--
--
380.55K
--
--
--
4.60M
--
286.53K
--
--
--
--
5.34M
150.94K
--
--
--
531.37K
682.31K
6.03M
164.70K
214.24M
-208.76M
--
--
--
5.64M
5.64M
11.67M
FY 2018-12-31
13.67M
--
--
--
--
--
0.00
--
--
--
616.22K
40.08K
14.33M
118.80K
--
--
--
--
--
--
440.99K
559.78K
14.89M
--
--
249.24K
--
--
--
5.81M
--
--
--
--
--
0.00
6.06M
13.35K
--
--
--
--
13.36K
6.08M
115.70K
195.55M
-186.86M
--
--
--
8.81M
8.81M
14.89M
FY 2017-12-31
17.40M
--
--
--
--
--
0.00
--
--
--
439.32K
0.00
17.84M
57.35K
--
--
--
--
--
--
440.80K
498.15K
18.34M
--
--
0.00
--
--
--
4.65M
--
--
--
--
--
15.92K
4.67M
0.00
--
--
--
--
0.00
4.67M
80.07K
176.74M
-163.15M
--
--
--
13.67M
13.67M
18.34M
FY 2016-12-31
20.52M
--
--
--
--
--
0.00
--
--
--
1.84M
34.73K
22.39M
88.55K
--
--
--
--
--
--
49.86K
138.41K
22.53M
--
--
0.00
--
--
--
4.22M
--
--
--
--
--
300.68K
4.52M
0.00
--
--
--
--
0.00
4.52M
55.80K
154.50M
-136.55M
--
--
--
18.01M
18.01M
22.53M
FY 2015-12-31
25.64M
--
--
--
--
--
0.00
--
--
--
803.46K
34.73K
26.48M
106.11K
--
--
--
--
--
--
0.00
106.11K
26.59M
--
--
265.70K
--
--
--
1.50M
--
--
--
--
--
2.85M
4.61M
0.00
--
--
--
--
0.00
4.61M
44.07K
134.16M
-112.23M
--
--
--
21.97M
21.97M
26.59M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out ATNM latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze ACTINIUM PHARMAC recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.